Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Nov, 16 2025
Feb, 4 2026
Dec, 21 2025
Oct, 6 2025
Mar, 22 2024